Efficacy, Safety and Dose Selection of AZD3759 in Patients with Untreated EGFR-mutated Non-Small-cell Lung Cancer and Central Nervous System Metastases in China (Ctong1702-Arm 8): a Multi-Center, Single-Arm, Phase 2 Trial
ECLINICALMEDICINE（2023）
Key words
EGFR mutation,CNS metastasis,AZD3759,Lung cancer,First-line setting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined